Tissue Repair Ltd (ASX:TRP)

Australia · Delayed Price · Currency is AUD

0.0950

+0.0050 (5.56%)

Oct 29, 2026, 1:54 PM AEDT

Market Cap	5.74M -68.9%
Revenue (ttm)	2.99M +13.6%
Net Income	-5.36M
EPS	-0.09
Shares Out	60.46M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,099
Open	0.0900
Previous Close	0.0900
Day's Range	0.0900 - 0.0950
52-Week Range	0.0550 - 0.4800
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 3, 2026

About Tissue Repair

Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and aesthetic procedure aftercare in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It also develops TR-987, a topical drug in Phase III clinical trial for the treatment of chronic wounds and venous leg ulcers; and TR Pro+, a post-procedure gel for the aftercare of acute ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2012

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol TRP

Full Company Profile

Financial Performance

In fiscal year 2026, Tissue Repair's revenue was 2.99 million, an increase of 13.58% compared to the previous year's 2.63 million. Losses were -5.36 million, 26.5% more than in 2025.

Financial Statements